Global Stem Cell Therapy Market Report and Forecast 2023-2031

Global Stem Cell Therapy Market Report and Forecast 2023-2031

Global Stem Cell Therapy Market Outlook

The global stem cell therapy market value was USD 246 million in 2022, driven by the increasing demand for regenerative therapies structure across the globe. The market size is anticipated to grow at a CAGR of 18.5% during the forecast period of 2023-2031 to achieve a value of USD 1133.4 million by 2031.

Stem Cell Therapy Introduction

Stem cells are unique, undifferentiated cells with the ability to differentiate into specialized cell types and self-renew to produce more stem cells. This extraordinary feature of stem cells has made them a subject of immense interest in regenerative medicine, as they hold the potential to repair or replace damaged or diseased tissues and organs. Stem cell research has led to ground-breaking advancements in the treatment of various conditions, including spinal cord injuries, Alzheimer's disease, Parkinson's disease, and cancer, among others.

Stem Cell Therapy Market Scenario

The global stem cell market has experienced significant growth in recent years, driven by factors such as the rising prevalence of chronic diseases, an aging population, and the increasing demand for regenerative therapies. The market has also been fueled by ongoing advancements in stem cell research, the development of novel stem cell-based therapies, and a supportive regulatory environment. Furthermore, the growing awareness of the potential benefits of stem cell therapies and increasing investments in research and development have contributed to the market's expansion.

North America: The largest market for stem cells, driven by factors such as advanced healthcare infrastructure, a strong focus on research and development, and the high prevalence of chronic diseases.

Europe: The second-largest market, with increasing demand for stem cell therapies due to a growing awareness of their potential benefits and a supportive regulatory framework.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.

Stem Cell Therapy Market Segmentations

Market Breakup by Treatment

• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy
• Syngeneic Stem Cell Therapy

Market Breakup by Product Type

• Adult Stem Cell
• Hematopoietic Stem Cells (Blood Stem Cells)
• Mesenchymal Stem Cells
• Neural Stem Cells
• Epithelial/Skin Stem Cells
• Other Adult Stem Cells
• Human Embryonic Cell
• Pluripotent Stem Cell
• Others

Market Breakup by Application

• Musculoskeletal Disorders
• Neurological Disorders
• Oncology Disorders
• Cardiovascular Disorders
• Cancers
• Wounds and Injuries
• Others

Market Breakup by Technology

• Cell Acquisition
• Bone Marrow Harvest
• Umbilical Blood Cord
• Apheresis
• Cell Production
• Therapeutic Cloning
• In Vitro Fertilization
• Cell Culture
• Isolation
• Cryopreservation
• Expansion And Sub-Culture

Market Breakup by End User

• Pharmaceutical And Biotechnology Companies
• Hospitals & Cell Banks
• Academic & Research Institutes

Market Breakup by Region

• North America
• United States of America
• Canada
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Asia Pacific
• China
• Japan
• India
• ASEAN
• Australia
• Others
• Latin America
• Brazil
• Argentina
• Mexico
• Others
• Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Key Trends in the Stem Cell Therapy Market

Some key trends of the market are as follows:

• Increasing demand for regenerative therapies: The growing prevalence of chronic diseases and an aging population have resulted in a higher demand for regenerative therapies, driving the growth of the stem cell market.
• Advancements in stem cell research: Ongoing research and development efforts have led to the discovery of novel stem cell-based therapies and techniques, fueling market growth.
• Supportive regulatory environment: Regulatory bodies worldwide are increasingly recognizing the potential benefits of stem cell therapies, leading to a more favorable environment for the development and commercialization of these treatments.

Stem Cell Therapy Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Thermo Fisher Scientific
• Bayer AG
• Stem Cell Therapys International Group, Ltd.
• Takeda Pharmaceutical Company Limited
• MEDIPOST Co., Ltd.
• JCR Pharmaceuticals Co., Ltd.
• Astellas Pharma Inc.
• Mesoblast Ltd.
• Novadip Biosciences S.A.
• Nuvasive Inc
• Molecular Devices Corporation
• Amgen Inc
• GENEA BIOCELLS
• WAISMAN BIOMANUFACTURING
• TIGENIX

*Please Note:* The report will be completed in 7 business days after order confirmation